List of Tables
Table 1: Percentage of people across age intervals with risk of developing cancer, United States, 2015-2017
Table 2: Key ADC parameters that require optimization for clinical efficacy
Table 3: Global ADC Market Size (USD Million), By Type, By Value, 2017-2027
Table 4: Global ADC Market Size (USD Million), By Application, By Value, 2017-2027
Table 5: Global ADC Market Size (USD Million), By Application, By Blood Cancer, By Value, 2017-2027
Table 6: Global ADC Market Size (USD Million), By End User, By Value, 2017-2027
Table 7: Global ADC Market Size (USD Million), By Region, By Value, 2017-2027
Table 8: North America ADC Market Size (USD Million), By Type, By Value, 2017-2027
Table 9: North America ADC Market Size (USD Million), By Application, By Value, 2017-2027
Table 10: North America ADC Market Size (USD Million), By Application, By Blood Cancer, By Value, 2017-2027
Table 11: North America ADC Market Size (USD Million), By End User, By Value, 2017-2027
Table 12: North America ADC Market Size (USD Million), By Region, By Value, 2017-2027
Table 13: Europe ADC Market Size (USD Million), By Type, By Value, 2017-2027
Table 14: Europe ADC Market Size (USD Million), By Application, By Value, 2017-2027
Table 15: Europe ADC Market Size (USD Million), By Application, By Blood Cancer, By Value, 2017-2027
Table 16: Europe ADC Market Size (USD Million), By End User, By Value, 2017-2027
Table 17: Europe ADC Market Size (USD Million), By Region, By Value, 2017-2027
Table 18: Asia-Pacific ADC Market Size (USD Million), By Type, By Value, 2017-2027
Table 19: Asia-Pacific ADC Market Size (USD Million), By Application, By Value, 2017-2027
Table 20: Asia-Pacific ADC Market Size (USD Million), By Application, By Blood Cancer, By Value, 2017-2027
Table 21: Asia-Pacific ADC Market Size (USD Million), By End User, By Value, 2017-2027
Table 22: Asia-Pacific ADC Market Size (USD Million), By Region, By Value, 2017-2027
Table 23: Latin America ADC Market Size (USD Million), By Type, By Value, 2017-2027
Table 24: Latin America ADC Market Size (USD Million), By Application, By Value, 2017-2027
Table 25: Latin America ADC Market Size (USD Million), By Application, By Blood Cancer, By Value, 2017-2027
Table 26: Latin America ADC Market Size (USD Million), By End User, By Value, 2017-2027
Table 27: Latin America ADC Market Size (USD Million), By Region, By Value, 2017-2027
Table 28: Middle East & Africa ADC Market Size (USD Million), By Type, By Value, 2017-2027
Table 29: Middle East & Africa ADC Market Size (USD Million), By Application, By Value, 2017-2027
Table 30: Middle East & Africa ADC Market Size (USD Million), By Application, By Blood Cancer, By Value, 2017-2027
Table 31: Middle East & Africa ADC Market Size (USD Million), By End User, By Value, 2017-2027
Table 32: Middle East & Africa ADC Market Size (USD Million), By Region, By Value, 2017-2027
Table 33: List of Antibody Drug Conjugates Patent
Table 34: List of Antibody Drug Conjugates Approved by FDA
Table 35: List of Antibody Drug Conjugates In Clinical trials
Table 36: ADC clinical trials in Recruiting Status
Table 37: List of ADC in Phase 1 Clinical Trials
Table 38: List of ADC in Phase 2 Clinical Trials
Table 39: List of ADC in Phase 3 Clinical Trials
Table 40: List of Key Players and Their Offerings
Table 41: Competitive Benchmarking, by Operating Parameters
Table 42: Antibody-Drug Conjugate Licensing and Merger and Acquisition (M&A) Deals.
Table 43: Takeda Pharmaceutical Company Limited Business Overview
Table 44: Takeda Pharmaceutical Company Limited Financial Analysis (USD Million)
Table 45: F. Hoffmann-La Roche AG Business Overview
Table 46: F. Hoffmann-La Roche AG Financial Analysis (USD Million)
Table 47: Pfizer Inc. Company Overview
Table 48: Pfizer Inc. Financial Analysis (USD Millions)
Table 49: AstraZeneca plc Company Overview
Table 50: AstraZeneca plc Financial Analysis (USD Millions)
Table 51: GiLead Sciences Inc. Business Overview
Table 52: GiLead Sciences Inc. Financial Analysis (USD Million)
Table 53: Astellas Pharma Inc. Business Overview
Table 54: Astellas Pharma Inc. Financial Analysis
Table 55: Seagen Inc. Business Overview
Table 56: Seagen Inc. Financial Analysis (USD Million)
Table 57: Daiichi Sankyo Company Ltd. Business Overview
Table 58: Daiichi Sankyo Company Ltd. Financial Analysis (USD Million)
Table 59: GlaxoSmithKline Plc. Limited Business Overview
Table 60: GlaxoSmithKline Plc. Financial Analysis (USD Million)
Table 61: Genentech, Inc. Business Overview
Table 62: F. Hoffmann-La Roche AG Financial Analysis (USD Million)
LIST OF FIGURE
List of Figures
Fig 1: Global ADC Market Segmentation
Fig 2: Global ADC Market Size (USD Million)
Fig 3: Global ADC Market, By Type (in %), 2020
Fig 4: Global ADC Market: Industry Value Chain
Fig 5: Global ADC Market: History of ADC development
Fig 6: Global ADC Market: Mechanism of Action
Fig 7: Porters Five Forces Analysis
Fig 8: Global ADC Market Size, By Value (USD Million), 2017-2027
Fig 9: Global ADC Market Share (%), By Type, By Value, 2017-2027
Fig 10: Global ADC Market Share (%), By Application, By Value, 2017-2027
Fig 11: Estimated Number of New Cases in 2020, Worldwide
Fig 12: Global ADC Market Share (%), By Application, By Blood Cancer, By Value, 2017-2027
Fig 13: Global ADC Market Share (%), By End User, By Value, 2017-2027
Fig 14: Global ADC Market Share (%), By Region, By Value, 2017-2027
Fig 15: North America ADC Market Size, By Value (USD Million), 2017-2027
Fig 16: North America ADC Market Share (%), By Type, By Value, 2017-2027
Fig 17: North America ADC Market Share (%), By Application, By Value, 2017-2027
Fig 18: North America ADC Market Share (%), By Application, By Blood Cancer, By Value, 2017-2027
Fig 19: North America ADC Market Share (%), By End User, By Value, 2017-2027
Fig 20: North America ADC Market Share (%), By Region, By Value, 2017-2027
Fig 21: Europe ADC Market Size, By Value (USD Million), 2017-2027
Fig 22: Europe ADC Market Share (%), By Type, By Value, 2017-2027
Fig 23: Europe ADC Market Share (%), By Application, By Value, 2017-2027
Fig 24: Europe ADC Market Share (%), By Application, By Blood Cancer, By Value, 2017-2027
Fig 25: Europe ADC Market Share (%), By End User, By Value, 2017-2027
Fig 26: Europe ADC Market Share (%), By Region, By Value, 2017-2027
Fig 27: Asia-Pacific ADC Market Size, By Value (USD Million), 2017-2027
Fig 28: Asia-Pacific ADC Market Share (%), By Type, By Value, 2017-2027
Fig 29: Asia-Pacific ADC Market Share (%), By Application, By Value, 2017-2027
Fig 30: Asia-Pacific ADC Market Share (%), By Application, By Blood Cancer, By Value, 2017-2027
Fig 31: Asia-Pacific ADC Market Share (%), By End User, By Value, 2017-2027
Fig 32: Asia-Pacific ADC Market Share (%), By Region, By Value, 2017-2027
Fig 33: Latin America ADC Market Size, By Value (USD Million), 2017-2027
Fig 34: Latin America ADC Market Share (%), By Type, By Value, 2017-2027
Fig 35: Latin America ADC Market Share (%), By Application, By Value, 2017-2027
Fig 36: Latin America ADC Market Share (%), By Application, By Blood Cancer, By Value, 2017-2027
Fig 37: Latin America ADC Market Share (%), By End User, By Value, 2017-2027
Fig 38: Latin America ADC Market Share (%), By Region, By Value, 2017-2027
Fig 39: Middle East & Africa ADC Market Size, By Value (USD Million), 2017-2027
Fig 40: Middle East & Africa ADC Market Share (%), By Type, By Value, 2017-2027
Fig 41: Middle East & Africa ADC Market Share (%), By Application, By Value, 2017-2027
Fig 42: Middle East & Africa ADC Market Share (%), By Application, By Blood Cancer, By Value, 2017-2027
Fig 43: Middle East & Africa ADC Market Share (%), By End User, By Value, 2017-2027
Fig 44: Middle East & Africa ADC Market Share (%), By Region, By Value, 2017-2027
Fig 45: Global ADC Market: Leading Companies
Fig 46: Global ADC Market: Market Share Analysis, 2020
